Skip to main content
. 2020 May 2;2020:4926819. doi: 10.1155/2020/4926819

Table 2.

Dermal changes of lesions among patients with cutaneous leishmaniasis.

Dermal change Category Number (%)
Type of inflammatory cells Lymphocytes Absent 0 (0)
Fewer in number to other cells 3 (6)
Equal in number to other cells 40 (80)
Dominates other cells 40 (80)
Plasma cells Absent 5 (10)
Fewer in number to other cells 27 (54)
Equal in number to other cells 18 (36)
Dominates other cells 0 (0)
Macrophages Absent 0 (0)
Fewer in number to other cells 3 (6)
Equal in number to other cells 25 (50)
Dominates other cells 22 (44)
Neutrophils Absent 16 (32)
Fewer in number to other cells 32 (64)
Equal in number to other cells 2 (4)
Dominates other cells 0 (0)
Eosinophils Absent 43 (86)
Fewer in number to other cells 7 (14)
Equal in number to other cells 0 (0)
Dominates other cells 0 (0)
Multinucleated giant cells Present 13 (26)
Absent 37 (74)

Nature of inflammatory infiltrate Macrophage predominant 22 (44)
Lymphocyte predominant 7 (14)
Lymphoplasmacytic 1 (2)
Lymphohistiocytic 9 (18)
Lymphohistioplasmacytic 11 (22)

Degree of inflammation Mild 5 (10)
Moderate 16 (32)
Extensive 29 (58)

Necrosis Absent 40 (80)
Focal 10 (20)
Diffuse 0 (0)

Neuritis Absent 45 (90)
Present 5 (10)

Granuloma Absent 9 (18)
Ill-defined granuloma 19 (38)
Well defined granuloma 22 (44)

Pattern of inflammation Diffuse infiltrate 9 (18)
Ill-defined histiocytic infiltrate 19 (38)
Well defined granuloma 22 (44)